Next Steps for Elevated Hemoglobin, Hematocrit, and MCV Without Symptoms
Order a complete metabolic panel with serum ferritin, transferrin saturation, vitamin B12, folate, JAK2 mutation testing, and reticulocyte count immediately to differentiate between polycythemia vera, secondary causes, and nutritional deficiencies. 1
Initial Laboratory Workup
The asymptomatic presentation does not exclude significant underlying pathology—elevated MCV with erythrocytosis creates a distinctive pattern requiring systematic evaluation:
- Confirm true polycythemia by repeating hemoglobin and hematocrit measurements, as single values are unreliable for diagnosis 1
- Obtain complete blood count with differential to assess white blood cell and platelet counts, which may reveal myeloproliferative features 1
- Measure serum ferritin and transferrin saturation to exclude iron deficiency, which paradoxically can coexist with erythrocytosis and cause microcytosis rather than macrocytosis 2, 3
- Check vitamin B12 and folate levels since deficiency of either causes macrocytosis and was identified in 24.1% and additional cases of macrocytosis in one study 4
- Order reticulocyte count to evaluate bone marrow response 1
- Measure serum erythropoietin (EPO) level to distinguish primary from secondary erythrocytosis—low EPO suggests polycythemia vera with >90% specificity 1, 3
JAK2 Mutation Testing
- Test for JAK2 V617F mutation (exon 14) and JAK2 exon 12 mutations immediately, as up to 97% of polycythemia vera cases carry these mutations 1
- If JAK2 is positive, refer immediately to hematology for bone marrow biopsy to confirm diagnosis and assess for trilineage myeloproliferation 1
Evaluate Secondary Causes
The elevated MCV narrows the differential but does not exclude secondary erythrocytosis:
- Order thyroid function tests as hypothyroidism can cause macrocytosis 4
- Obtain liver function tests since liver disease accounts for a proportion of macrocytosis cases 4
- Review medication history for drugs causing macrocytosis (hydroxyurea, antiretrovirals, chemotherapy agents), which accounted for 12.9% of macrocytosis in one series 4
- Assess alcohol consumption, as alcoholism was the leading cause of macrocytosis in 36.5% of cases 4
- Consider sleep study if clinical features suggest obstructive sleep apnea, which causes nocturnal hypoxemia driving erythropoietin production 1
- Obtain pulse oximetry at rest for at least 5 minutes to assess for hypoxemia 2
- Review for smoking history as "smoker's polycythemia" results from chronic carbon monoxide exposure causing tissue hypoxia 1
Critical Diagnostic Considerations
The combination of elevated hemoglobin/hematocrit with elevated MCV is unusual and requires careful interpretation:
- Polycythemia vera typically presents with normal or low MCV due to iron depletion from increased red cell production 3
- Elevated MCV in the context of erythrocytosis suggests either coexisting B12/folate deficiency, alcohol use, liver disease, medication effect, or possibly hemochromatosis 4, 5
- Check peripheral blood smear for macro-ovalocytes and hypersegmented neutrophils (suggesting megaloblastic anemia) or other morphologic abnormalities 1, 4
Management Thresholds
Do not perform therapeutic phlebotomy at this stage:
- Phlebotomy is indicated only when hemoglobin exceeds 20 g/dL and hematocrit exceeds 65% with hyperviscosity symptoms (headache, dizziness, visual changes) after excluding dehydration 2, 1
- Repeated routine phlebotomies are contraindicated due to risk of iron depletion, decreased oxygen-carrying capacity, and paradoxically increased stroke risk 2, 1
- The absence of symptoms does not eliminate thrombotic risk—asymptomatic patients with polycythemia vera still require treatment to maintain hematocrit <45% once diagnosed 1
Common Pitfalls to Avoid
- Do not assume the elevated MCV excludes polycythemia vera—patients can have coexisting nutritional deficiencies or other causes of macrocytosis 3, 4
- Do not give iron supplementation before establishing the diagnosis, as this can worsen hyperviscosity and thrombotic risk if polycythemia vera is present 3
- Do not dismiss the findings due to lack of symptoms—hyperviscosity symptoms are unlikely with hematocrit <65%, but thrombotic risk exists at lower levels in polycythemia vera 2, 1
- Do not use MCV alone to screen for iron deficiency in erythrocytosis, as it is unreliable in this context—serum ferritin and transferrin saturation are required 1